Business Fortune
Risk-driven Quality Consulting Company LLC, or RdQCC, was founded on a forward-thinking approach to pressing business issues. The founders, under the direction of Jerry (Jinxing) Xiao, were motivated by the need to protect patient safety and transform product risk management. They use state-of-the-art AI technology in conjunction with their vast experience in product risk assessment to create applications such as www.risk-discovery.com, an AI-powered risk search engine with over 3000 users worldwide. RdQCC has become a leader in AI-powered risk management solutions, with a strong focus on innovation, product risk management expertise, and a customer-centric approach. The company aims to become the first provider of AI risk modules and a risk data center for medical devices.
California's San Diego is home to RdQCC.
The proprietor of RdQCC, Jerry (Jinxing) Xiao, was contacted by The Business Fortune. This is his response.
Interview Highlights
What maintains RdQCC's relevance over time? What areas are its priorities?
RdQCC is significant because of its steadfast dedication to tackling the most important issues facing the medical technology sector. Utilizing AI technology to meet the specific needs of each customer, producing high-quality outputs for risk detection and reduction, generating knowledge for product development, and proactively preserving the safety of users and patients through the mining of medical device data and cooperation with subject matter experts (SMEs) are some of its key focus areas.
The innovative leadership team at RdQCC successfully integrates OpenAI models like ChatGPT-3.5 into their applications to create AI-powered product risk management. They do this by utilizing their extensive knowledge in semantic analysis and cognitive psychology, as well as their research in product risk assessment. RdQCC's dedication to innovation places it at the forefront of AI-powered product risk management. Its short-term objectives are to develop AI risk modules, and its long-term goal is to establish itself as a global hub for medical device risk data.
Could you provide us an overview of your offerings? What distinguishing qualities do they have?
The three AI-powered risk management options that RdQCC provides are listed below. We can also help our clients set up their own AI-based risk management solutions.
Risk Search Engine (www.risk-discovery.com): A thorough risk assessment for failure modes, hazards, hazardous circumstances, harms, failure causes, and risk mitigations is offered by this platform to the general public. By choosing particular product categories or training by their data, like cardiovascular, registered users can further improve their experience and provide outputs that are high-quality and customized.
Risk Chat (www.risk-chat.com): With the freedom to direct and personalize talks on risk-related subjects, it gives users the opportunity to choose the language, structure, length, and level of detail that best suits their needs. Users can gain comprehensive insights into a range of risk concerns, including preventive measures, safety-related information, and risk mitigations pertaining to intrinsic safety, through iterative discussions.
Risk Embedded solution (RdPDM): With the use of the risk search engine or risk chat tools, users can continue their FMEA worksheets, including design FMEA, Hazard Analysis, process FMEA, usage FMEA, and software FMEA, thanks to RdPDM's smooth integration with Microsoft Excel. Furthermore, with the help of the risk search engine and risk chat tools, users may easily write documentation, including test verification protocols, validation protocols, and IFU, thanks to RdPDM's integration with Microsoft Word.
How does RdQCC generate and sustain a culture of innovation?
RdQCC uses cutting-edge AI technologies for product risk management to foster an innovative culture. The way experts in the medical device industry anticipate and reduce risks is being revolutionized by our AI-powered products, which include the risk search engine, risk chat, and embedded solution. With expert-reviewed training data, we continuously improve our models to produce better outcomes and faster response times. Our goal is to safeguard innovation while safeguarding patients, which motivates us to build cutting-edge AI-powered solutions for safer, more effective product development.
Tell us about the RDQCC team. What value do they bring to the company?
The RdQCC team is a diverse and highly skilled group of professionals who bring immense value to the company. Led by myself, the team boasts extensive experience in roles like quality engineering, design assurance, linguistics scientist, and risk management. They are complemented by experts like Shahar Tsadeek (lead data scientist), Jiashen Kang (lead software developer), and John Spanomanolis (lead risk management SMEs), each with specialized knowledge crucial to our operations. With advisors and supporting teams, RdQCC is guided by a wealth of expertise, ensuring excellence in product risk management and innovation.
What is the one thing you would like the RDQCC to be recognized for?
We want RdQCC to be recognized as a leader in the analysis of risk data for medical devices and as a cutting-edge supplier of AI-powered product risk management. What distinguishes us is our steadfast dedication to safeguarding innovation and ensuring user safety within the medical device sector. Our goal is to become the industry leader in this field by providing thorough and superior solutions that enable experts to anticipate and reduce hazards in advance. By integrating AI risk modules with current product risk management systems, we hope to become the go-to source for product development solutions that promote both efficiency and safety. In the end, we want RDQCC to be associated with state-of-the-art technology that protects patients' and users' health all over the world.
Jerry (Jinxing) Xiao | Owner of RdQCC
A wide range of leading medical device firms, such as Medtronic, J&J (Biosense Webster, Ethicon, Abiomed), Philips Healthcare, Becton Dickinson, Zimmer Biomet, Abbott, DJO Global, and ICU Medical, have hired Jerry (Jinxing) Xiao as a consultant. Additionally, he offers assistance to small and medium-sized businesses, including Verb Surgical (Google+JnJ), Intouch Health, Vyaire Medical, Syncardia, and others.
Important equipment such as the whole artificial heart, heart pump, pacemaker, implantable cardioverter defibrillator (ICD), robotic surgery, pump (insulin, infusion), ventilator, orthopedic product, lead, etc. are covered by his competence in product risk management.
Jerry (Jinxing) Xiao is a Master's degree holder in Quality System Engineering and an ASQ certified professional.
